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Abstract
Introduction: There are conflicting data on the natural history and clinical significance of bone marrow lesions
(BMLs). The aims of this study were to describe the natural history of MRI-detected BMLs at the knee using a
quantitative measure and examine the association of BMLs with pain, function and stiffness scores, and total knee
replacement (TKR) surgery.
Methods: A total of 395 older males and females were randomly selected from the general population (mean age
63 years, range 52 to 79) and measured at baseline and approximately 2.7 years later. BMLs were determined using
T2-weighted fat saturation MRI by measuring the maximum area of the lesion. Reproducibility was excellent
(intraclass correlation coefficient (ICC): 0.97). Pain, function, and stiffness were assessed by Western Ontario and
McMaster Universities Osteoarthritis (WOMAC) scores. X-ray was used to assess radiographic osteoarthritis (ROA) at
baseline.
Results: At baseline, 43% (n = 168/395) had a BML. Of these 25% decreased in size and 24% increased. Of the
remaining sample (n = 227), 7% developed a new BML. In a multivariable model, a change in BML size was
associated with a change in pain and function scores (b = 1.13 to 2.55 per 1 SD increase, all P < 0.05), only in
those participants without ROA. Lastly, baseline BML severity predicted TKR surgery (odds ratio (OR) 2.10/unit, P =
0.019).
Conclusions: In a population based sample, BMLs (assessed by measuring maximal area) were not static, with
similar proportions both worsening and improving. A change in BML size was associated with changes in pain in
those without established ROA. This finding suggests that fluctuating knee pain may be attributable to BMLs in
those participants with early stage disease. Baseline BMLs also predicted TKR surgery. These findings suggest
therapeutic interventions aimed at altering the natural history of BMLs should be considered.
Introduction
Osteoarthritis (OA) is a multifactorial disease of the joints
characterized by gradual loss of articular cartilage. There
is strong evidence that bone plays an important role in
the pathogenesis of OA and it has been suggested
that bone changes may precede cartilage damage [1].
Recently we have shown that elevated tibial bone area
and subchondral bone mineral density (BMD) predicted
cartilage defect increases [2]. Additionally, tibial bone
area predicted cartilage volume loss. Bone marrow lesions
(BMLs) have also been recognized as an important fea-
ture of knee OA [3,4]. They are associated with structural
changes in the knee, including joint space loss on radio-
graphs [4], cartilage defect progression [5] and cartilage
loss on MR images [5-7]. BML histology is heterogeneous
and includes a mix of pathological changes. Zanetti et al.
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undergoing total knee replacement consisted of several
abnormalities including bone marrow necrosis, abnormal
trabeculae, bone marrow fibrosis, bone marrow bleeding,
and bone marrow oedema [8]. BMLs have also been
described in other rheumatic conditions such as rheuma-
toid arthritis (RA) [9], osteonecrosis [10], ankylosing
spondylitis [11], and transient osteoporosis of the hip
[12] and are often referred to as bone marrow oedema
(BME). In RA, it is suggested that BME represents cellu-
lar infiltrate within the subchondral bone [9] and is asso-
ciated with painful and aggressive disease [13]. Although
BMLs in OA and BME in RA appear similar on MR
images, it is unclear whether they are under the same
pathological processes.
There are conflicting data on the natural history of
BMLs in knee OA. Most studies have focused on symp-
tomatic OA populations. One study reported that <1%
of patients showed a BML decrease over 30 months [6],
while, in contrast, another study found that 20% of
BMLs decreased over two years [14]. In subjects with
prevalent knee OA or at risk for OA, Roemer et al.
f o u n dt h a tt h em a j o r i t y( 5 0 % )o fp r e - e x i s t i n gB M L s
decreased in size after 30 months follow-up [15]. The
reasons behind these variations are unclear.
A number of studies have linked BMLs with knee pain
[3,16,17] although other studies have failed to demon-
strate such a relationship [14,18,19]. In pain-free popula-
tions, incident BMLs [17] and increases in BMLs [16]
have been shown to be associated with development of
knee pain. However, other studies in mostly OA subjects
have reported no association between changes in BMLs
and Western Ontario and McMaster Universities
Osteoarthritis (WOMAC) index pain scores at baseline
[19], WOMAC scores after two years [14], or changes in
WOMAC scores [18]. Importantly, it remains unknown
whether reduction or resolution of BMLs is associated
with improved knee pain. Furthermore, patients with
OA experience stiffness and limited function; however,
there are little data on the association between function,
stiffness and BMLs.
Another important clinical outcome in knee OA is
joint replacement surgery. It is well-established that
radiographic severity and pain are strong predictors of
joint replacement surgery [20,21]; however, there have
been limited prospective studies examining structural
factors and knee replacement surgery. In subjects with
symptomatic knee OA, ultrasound detected effusion
[22], articular cartilage defects [23], rate of tibial carti-
lage loss and tibial bone size [24] predicted knee joint
replacement. A recent study by Tanamas et al. showed
that the severity of BMLs was positively associated with
the risk of knee joint replacement in subjects with well-
established OA [25]. It is unknown whether BMLs in a
community-based sample also predict knee joint
replacement.
The conflicting data on the natural history and clinical
significance of BMLs may be due to studies grading
BMLs semi-quantitatively, based on the extent of regio-
nal involvement. A truly quantitative measure of BML
size may give more insight into actual changes over
time. Therefore, this study aimed to: 1) describe the nat-
ural history of BMLs in a population based sample using
a quantitative measure; and 2) examine the clinical cor-
relates of BMLs, including pain, function, and stiffness
scores and total knee replacement surgery.
Materials and methods
Subjects
This study was conducted as part of the Tasmanian
Older Adult Cohort (TASOAC) study, a prospective,
population-based study that was initiated in 2002 aiming
to identify the environmental,g e n e t i c ,a n db i o c h e m i c a l
factors associated with the development and progression
of OA at multiple sites (hand, knee, hip, and spine).
Subjects between the ages of 50 and 80 years where ran-
domly selected from the electoral roll in Southern Tas-
mania (population 229,000), with an equal number of
men and women. The overall response rate was 57%.
The study included a baseline examination and follow-
up examinations at approximately 2.7 and 5 years. The
research conducted in this manuscript is in compliance
with the Helsinki Declaration and was approved by the
Southern Tasmanian Health and Medical Human
Research Ethics Committee. Written informed consent
was obtained from all participants.
Anthropometrics
Weight was measured to the nearest 0.1 kg (with shoes,
socks, and bulky clothing removed) using a single pair
of electronic scales (Seca Delta Model 707, Bradford,
MA, USA). Height was measured to the nearest 0.1 cm
(with shoes and socks removed) using a stadiometer.
Body mass index (BMI) was calculated (kg/m
2).
Magnetic Resonance Imaging
An MRI of the right knee was acquired with a 1.5T
whole-body magnetic resonance unit (Picker, Cleveland,
OH, USA) using a commercial transmit-receive extre-
mity coil at baseline and at the first follow-up (range 2.0
to 4.7 years, median 2.7 years). Image sequence included
the following: (1) a T1-weighted fat saturation three-
dimensional (3-D) gradient recall acquisition in the
steady state, flip angle 30°, repetition time 31 ms, echo
time 6.71 ms, field of view 16 cm, 60 partitions, 512 ×
512-pixel matrix, acquisition time 5 minutes 58 seconds,
one acquisition; sagittal images were obtained at a slice
thickness of 1.5 mm without a interslice gap; (2) a
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90°, repetition time 3,067 ms, echo time 112 ms, field of
view 16 cm, 15 partitions, 228 × 256-pixel matrix; sagit-
tal images were obtained at a slice thickness of 4 mm
with a interslice gap of 0.5 to 1.0 mm.
Subchondral BMLs were assessed on T2-weighted MR
images using Osiris software (University of Geneva,
Geneva, Switzerland) and were defined as areas of
increased signal adjacent to the subcortical bone at the
medial tibial, medial femoral, lateral tibial, and lateral
femoral sites. One trained observer scored the BMLs by
measuring the maximum area of the lesion at baseline
and at the first follow-up. The observer manually
selected the MRI slice with the greatest BML size. The
B M Lw i t ht h eh i g h e s ts c o r ew a su s e di fm o r et h a no n e
lesion was present at the same site. The maximum area
was measured in mm
2 using software cursors. Baseline
and follow-up MRIs were read paired with the chrono-
logical order known to the observer and the observer
blinded to clinical status. Intraobserver repeatability was
assessed in 40 subjects with at least a two-week interval
between the readings. The intraclass correlation coeffi-
cient (ICC) was 0.97. At baseline and the first follow-up,
participants were given a BML score (mm
2) for each of
the four sites (medial tibial, medial femoral, lateral tibial,
and lateral femoral sites) as well as a total BML score,
which was the sum of the scores at each site. Figure 1a
& 1 bi l l u s t r a t e sac h a n g ei n BML size from baseline to
follow-up.
Bone marrow lesions were also assessed at baseline on
an ordinal scale by a different observer as we have pre-
viously reported [26]. Each BML was scored on the
basis of lesion size (for example, a lesion was scored as
grade 1 if it was only present on one slice, grade 2 if
present on two consecutive slices, or grade 3 if present
on three or more consecutive slices). The BML with the
highest score was used if more than one lesion was pre-
sent at the same site. Intraobserver repeatability was
assessed in 50 subjects with at least a one-week interval
between the two readings with ICCs ranging from 0.89
to 1.00. The BML score was summed for all four sites
to produce a total BML score (ranging from 0 to 12).
WOMAC scores
Knee pain, function, and stiffness were assessed by self-
administered questionnaire (WOMAC) [27], at baseline
a n dt h ef i r s tf o l l o w - u p .W O M A Cu s e sa1 0 - p o i n ts c a l e
from 0 (no pain, stiffness, or function deficit) to 9 (most
severe pain, stiffness or severe function problems). Knee
pain, function, and stiffness assessments consisted of 5,
17, and 2 questions each; therefore, the range for each
of these is from 0 to 45, 0 to 153, and 0 to 18,
respectively.
In further analysis, knee pain was assessed using the
five sub-scales, which included knee pain while walking
on a flat surface, going up and down stairs, at night
while in bed, sitting or lying, and standing upright.
These ranged from 0 to 9.
Subjects also completed a questionnaire on medication
use at baseline and the first follow-up.
Knee replacement surgery
At the two follow-up visits, participants were asked
whether they had undergone a total knee replacement
since their first visit. Although MRI scans were taken of
the right knee only at baseline, replacement surgery data
were collected for both knees.
Additional available baseline data
A standing anteroposterior semiflexed view of the right
knee with 15° of fixed knee flexion was performed and
scored individually for osteophytes and joint space nar-
rowing (JSN) on a scale of 0 to 3 (0 = normal and 3 =
severe) according to the Altman atlas [28] as previously
described [29]. The presence of radiographic OA (ROA)
was defined as any score ≥1 for JSN or osteophytes.
Leg strength was measured by a dynamometer (TTM
Muscular Meter; Gloria, Tokyo, Japan) with both legs
involved simultaneously. The muscles measured with
this technique are predominantly quadriceps and hip
flexors. Subjects were instructed in the technique before
testing. Each subject had two attempts, and an average
of the two was taken. The repeatability estimate was
0.91 (Cronbach’s a).
The Assessment of Quality of Life (AQoL) instrument
was used to measure health-related quality of life. The
AQoL is a valid [30] measure of quality of life, with
reliability in a population-based study of 0.81 (Cron-
bach’s a) [31]. The total AQoL score ranged from 0
(perfect health) to 45 (worst possible health state).
Cartilage defects were assessed by a trained observer
on T1-weighted MR images (score range, 0 to 4) at the
tibial and femoral sites, medially and laterally, as pre-
viously described [32] as follows: grade 0 = normal carti-
lage; grade 1 = focal blistering and intracartilaginous
low-signal intensity area with an intact surface and base;
grade 2 = irregularities on the surface or base and loss
of thickness <50%; grade 3 = deep ulceration with loss
of thickness >50%; and grade 4 = full-thickness chondral
wear with exposure of subchondral bone. A cartilage
defect had to be present on at least two consecutive
slices. The cartilage was considered to be normal if the
band of intermediate signal intensity had a uniform
thickness. If >1 defect was present on the same site
the highest score was used. Intraobserver repeatability
was assessed in 50 subjects with at least one week
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0.80 to 0.95.
Knee tibial plateau bone area was measured and
defined as the cross-sectional surface area of the tibial
plateau, as previously described [33-35]. The coefficient
of variation (CV) in our hands for this method of mea-
surement ranged from 2.2 to 2.6% [34].
Statistical analysis
In order to examine the natural history of BMLs a sig-
nificant change in BML size was defined as any change
above (increase) or below (decrease) the least significant
criterion (LSC) [36], which takes into account measure-
ment error and the correlation between the BML mea-
surements at baseline and follow-up. The formula was
as follows:
LSC =× − 19 6 21 .( ) 
where s is the standard error of the mean and r is the
serial correlation. LSC was calculated to be 25 mm
2
(where s = 11.67 and r = 0.3810). Therefore an increase
i nB M Ls i z ew a sa n yc h a n g ea b o v e2 5m m
2,w h i c h
included new or progressing BMLs. A decrease in BML
size was any decrease greater than 25 mm
2,w h i c h
included resolved or regressing BMLs.
Logistic regression analysis was used to examine the
association between baseline BMLs (absent versus pre-
sent) and increases in BMLs (no increase or incident
BML versus increase or incident BML) and demographic
factors such as age, sex, and BMI.
Mixed effects models were used to account for the
correlated readings within an individual and examine
the association between changes in WOMAC scores
(pain, function, and stiffness) and continuous changes in
BML size. Standard diagnostic checks of model ade-
quacy and unusual observations were performed and
revealed that some of the models were heteroscedastic.
This is due to the fact that much of the data is clumped
at zero because BMLs were measured at four separate
sites and the majority of participants who had a BML
present had it at only one of the four sites. To our
knowledge there is no commercially available software
to deal with data of this sort in longitudinal analysis. As
a result we have performed two separate analyses exam-
ining, 1) BML size change at all four sites (medial tibial,
medial femoral, lateral tibial, and lateral femoral); and
2) total BML size change (all four sites combined).
Figure 1 Change in BML size. (a) BML increase from baseline to first follow-up. (b) BML decrease from baseline to first follow-up.
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results. We also stratified the analysis by presence or
absence of ROA, as the results were quite different for
each sub-group.
Over the course of the study period (five years), there
were 12 knee replacements; therefore, we were only able
to perform an exploratory analysis between BMLs and
knee replacement surgery. Logistic regression and exact
logistic regression modelling were used to examine
whether baseline BMLs measured using the ordinal
scale predicted knee replacement surgery after adjust-
ment for potential confounders.
All statistical analyses were performed on Intercooled
Stata 10.0 for windows (StataCorp, College Station, TX,
USA).
Results
Characteristics of the study subjects
A total of 1,099 subjects (51% female) aged between 51
and 81 (mean 63 years) participated in the TASOAC
study. The current study consists of a sample of 395
participants who had MRI measures at baseline and the
first follow-up. MRI scans were discontinued after this
sample due to decommissioning of the MRI scanner.
Additional data on knee replacement surgery were avail-
able on these subjects at the second follow-up. At
baseline, there were no significant differences in demo-
graphics, ROA, WOMAC function or stiffness scores,
AQoL scores, or leg strength between the rest of the
cohort (n = 704) and the subjects included in the cur-
rent study (n = 395). There was a small difference in the
WOMAC pain scores between the subjects in the cur-
rent study [mean pain score 3.2 (standard deviation
(SD) 6.3) compared with the rest of the cohort [mean
pain score 4.1 (SD 6.4); P = 0.03 for difference). The
characteristics of the study population are presented in
Table 1.
Natural history and demographic factors
At baseline, 43% of participants (n = 168/395) had one
or more BML present at the medial tibial, medial
femoral, lateral tibial, and/or lateral femoral site. A total
of 114 subjects had a BML at one site only, 43 had a
BML at two sites, 10 had a BML at three sites, and 1
had a BML at all four sites. Therefore, at all four sites
combined, there were 234 total BMLs present at
baseline.
The overall prevalence in those with (43%) and with-
out ROA (41%) was similar; however, those with ROA
had more total BMLs present (144) compared to those
without ROA (80). In those with ROA, 58 subjects had
aB M La to n es i t eo n l y ,2 6h a daB M La tt w os i t e s ,1 0
h a daB M La tt h r e es i t e s ,a n d1h a daB M La ta l lf o u r
sites. Those without ROA had BMLs present at one or
two sites only; 50 had a BML at one site and 15 had a
BML at two sites.
Table 2 describes the association between baseline
BMLs and increasing BMLs with baseline demographic
factors. Those who had a BML present at baseline had a
higher BMI and were more likely to be male. Males
were also more likely to have a BML increase. Age or
BMI did not predict BML increases.
Figure 2 describes the natural history of BMLs in the
whole population and split by ROA. About half the
lesions present at baseline remained stable, with similar
proportions both worsening and improving. Those with
ROA had higher odds of a BML increasing compared to
those without ROA (odds ratio (OR) 2.2, P = 0.017).
This was the only significantd i f f e r e n c ei nt h en a t u r a l
history between those with and without ROA.
O ft h o s et h a td i dn o th a v eaB M La tb a s e l i n e( n =
227), 7% developed one or more BMLs from baseline to
follow up. Incidence was also similar for those with
(7.2%) and without ROA (6.5%).
WOMAC scores and BMLs
Table 3 describes the association between changes in
WOMAC scores and changes in BML size, stratified by
R O A .Ac h a n g ei nk n e ep a i na n df u n c t i o nw a sa s s o -
ciated with a change in BML size at all four sites, but
only in those participants without ROA. These results
were also consistent when using change in total BML
size (all four sites combined) as the independent factor.
Importantly the association between change in function
and change in BML size disappeared after further
adjustment for change in pain (b = 0.10 to 0.23, P >
Table 1 Characteristics of participants at baseline
(n = 395)
Value*
Age (year) 63.2 (7.2)
Male sex (%) 49
Height (cm) 167.2 (8.8)
Weight (kg) 77.3 (14.2)
BMI (kg/m
2) 27.6 (4.5)
ROA present (%) 58
BML present (%) 43
Mean BML size (mm
2) 72.7 (74.6)
WOMAC
Pain (0 to 45) 3.2 (6.3)
Function deficit (0 to 153) 10.4 (21.9)
Stiffness (0 to 18) 1.5 (2.9)
Leg strength (kg) 92.3 (47.5)
AQoL (0 to 29) 7.0 (5.0)
*Mean (SD) except for percentages. AQoL, Assessment of Quality of Life; BMI,
body mass index; BML, bone marrow lesion; ROA, radiographic osteoarthritis;
WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
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changes in function and changes in BML size is
mediated by changes in pain. In those without ROA, a
o n eS Di n c r e a s ei nt o t a lB M Ls i z el e dt oa1 . 1 3 - u n i t
increase in pain (P = 0.009). Similarly, a one SD
decrease in total BML size led to a 1.13 decrease in pain
(P = 0.009), in those without ROA. There were no asso-
ciations between changes in pain, function, or stiffness
and changes in BML size (at all four sites or total BML
size) in those with ROA.
Table 4 describes the association between changes in
the five WOMAC pain sub-scales and changes in BML
size, stratified by ROA. Changes in knee pain when
walking on a flat surface, going up and down stairs, and
at night while in bed was associated with changes in
BML size at all four sites, again only in those partici-
pants without ROA. These results were also consistent
when using change in total BML size (all four sites com-
bined) as the independent factor. There were no associa-
tions between changes in any of the five WOMAC pain
Table 2 Relationship between baseline BMLs and increasing BMLs with baseline demographic factors*
Univariate OR (95% CI) P Multivariable OR (95% CI)† P
Absence/Presence of BML at baseline
Age 1.00 (0.82, 1.22) 0.992 0.99 (0.80, 1.21) 0.905
Male sex 1.61 (1.08, 2.41) 0.020 1.70 (1.13, 2.56) 0.011
BMI 1.31 (1.07, 1.61) 0.009 1.34 (1.09, 1.65) 0.005
BML increase at any site**
Age 1.10 (0.86, 1.40) 0.463 1.08 (0.84, 1.39) 0.529
Male sex 1.74 (1.05, 2.86) 0.030 1.78 (1.07, 2.95) 0.026
BMI 1.19 (0.94, 1.51) 0.146 1.23 (0.97, 1.58) 0.093
*Values are per one standard deviation increase in respective variable (except sex).
OR, odds ratio; 95% CI, 95% confidence interval; BMI, body mass index; BMLs, bone marrow lesions
**No increase or incident BML versus an increase or incident BML at any site (medial tibial, medial femoral, lateral tibial, and/or lateral femoral)
†Adjusted for sex and BMI in the age model, age and BMI in the sex model, or age and sex in the BMI model.
Boldface denotes statistically significant result.
Figure 2 Natural history of BMLs. *Those with ROA had higher odds of a BML increasing compared to those without ROA (OR 2.2, P = 0.017).
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total BML size) in those with ROA.
Additional analyses in which we adjusted for baseline
pain medication use or changes in pain medication did
not alter our results, nor did separate adjustments for non-
steroidal anti-inflammatory drugs (NSAIDs). The results
also remained unchanged after adjustment for tibial bone
area and subchondral bone mineral density (sBMD).
Knee replacement surgery
There were 12 total knee replacements from baseline to
the five-year follow-up and baseline BML data assessed
Table 3 Relationship between changes in WOMAC scores and changes in BML size*
BML size change at all four sites** Total BML size change
Univariate (95%
CI)
P Multivariable (95%
CI)†
P Univariate (95%
CI)
P Multivariable (95%
CI)†
P
No ROA
Pain change 0.57 (0.15, 0.99) 0.008 0.56 (0.19, 0.92) 0.003 1.06 (0.10, 2.03) 0.031 1.13 (0.28, 1.98) 0.009
Function
change
1.20 (-0.08, 2.47) 0.067 1.25 (0.22, 2.28) 0.017 2.23 (-0.71, 5.17) 0.136 2.55 (0.14, 4.95) 0.038
Stiffness change -0.01 (-0.20, 0.18) 0.925 0.04 (-0.13, 0.20) 0.664 -0.02 (-0.46, 0.43) 0.947 0.09 (-0.29, 0.48) 0.641
ROA Present
Pain change 0.07 (-0.29, 0.43) 0.715 0.03 (-0.28, 0.35) 0.844 0.11 (-0.54, 0.77) 0.733 0.06 (-0.53, 0.64) 0.848
Function
change
0.16 (-0.77, 1.08) 0.740 0.13 (-0.62, 0.89) 0.729 0.26 (-1.41, 1.94) 0.756 0.23 (-1.17, 1.63) 0.750
Stiffness change 0.03 (-0.13, 0.19) 0.723 0.03 (-0.11, 0.17) 0.655 0.04 (-0.25, 0.34) 0.772 0.05 (-0.21, 0.30) 0.721
*Values are the change in pain, function, or stiffness score per one standard deviation change in BML size (mm
2), stratified by ROA.
BML, bone marrow lesion; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; ROA, radiographic osteoarthritis.
b, beta coefficients; 95% CI, 95% confidence interval.
**Medial tibial, medial femoral, lateral tibial, and lateral femoral.
†Adjusted for age, sex, body mass index, leg strength, quality of life, and baseline pain, function, or stiffness score depending on the model.
Boldface denotes statistically significant result
Table 4 Relationship between changes in the five WOMAC pain sub-scales and changes in BML size*
BML size change at all 4 sites ** Total BML size change
Univariate (95%
CI)
P Multivariable (95%
CI)†
P Univariate (95%
CI)
P Multivariable (95%
CI)†
P
No ROA
Walking on a flat
surface
0.15 (0.05, 0.26) 0.005 0.14 (0.06, 0.22) 0.001 0.30 (0.05, 0.54) 0.018 0.29 (0.11, 0.48) 0.002
Going up and down
stairs
0.16 (0.04, 0.28) 0.008 0.15 (0.05, 0.25) 0.003 0.33 (0.05, 0.60) 0.020 0.33 (0.09, 0.57) 0.006
At night while in bed 0.13 (0.03, 0.23) 0.014 0.11 (0.04, 0.18) 0.002 0.22 (-0.01, 0.45) 0.066 0.21 (0.04, 0.38) 0.014
Sitting or lying 0.06 (-0.03, 0.15) 0.172 0.07 (-0.01, 0.15) 0.073 0.11 (-0.10, 0.31) 0.314 0.14 (-0.04, 0.33) 0.130
Standing upright 0.06 (-0.03, 0.15) 0.160 0.08 (-0.001, 0.16) 0.054 0.12 (-0.09, 0.33) 0.271 0.16 (-0.03, 0.35) 0.089
ROA present
Walking on a flat
surface
-0.02 (0.08, 0.05) 0.652 -0.02 (0.08, 0.05) 0.617 -0.02 (-0.15, 0.10) 0.686 -0.03 (-0.14, 0.09) 0.645
Going up and down
stairs
0.02 (-0.07, 0.12) 0.660 0.02 (-0.06, 0.11) 0.601 0.03 (-0.14, 0.20) 0.722 0.03 (-0.12, 0.19) 0.673
At night while in bed 0.03 (-0.07, 0.14) 0.534 0.01 (-0.07, 0.09) 0.871 0.05 (-0.14, 0.25) 0.589 0.01 (-0.13, 0.16) 0.850
Sitting or lying 0.01 (-0.08, 0.10) 0.863 -0.01 (-0.08, 0.06) 0.827 0.01 (-0.15, 0.17) 0.895 -0.01 (-0.14, 0.12) 0.847
Standing upright 0.03 (-0.05, 0.12) 0.431 0.01 (-0.06, 0.07) 0.800 0.05 (-0.10, 0.21) 0.504 0.01 (-0.11, 0.14) 0.814
*Values are the change in pain sub-scale score per one standard deviation change in BML size (mm
2), stratified by ROA.
b, beta coefficients; 95% CI, 95% confidence interval; BML, bone marrow lesion; ROA, radiographic osteoarthritis; WOMAC, Western Ontario and McMaster
Universities Osteoarthritis Index.
**Medial tibial, medial femoral, lateral tibial, and lateral femoral.
† Adjusted for age, sex, body mass index, leg strength, quality of life, and baseline pain sub-scale score depending on the model. Boldface denotes statistically
significant result.
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The ordinal and areal BML measures were done by two
separate readers and the correlation between the two
was high (r = 0.79, P < 0.001).
Seventy-five percent (9/12) of participants who had a
knee replacement had a BML at baseline. Table 5 exam-
ines the relationship between knee replacement surgery
and baseline BMLs. An exploratory analysis revealed
that in univariate analysis baseline BMLs in the right
knee predicted incident knee replacement of the left,
right, and right and left knee combined. Baseline BML
severity of the right knee was a stronger predictor of a
right knee replacement (OR 2.75/unit, P <0 . 0 1 ) ;h o w -
ever, also predicted left knee replacement (OR 1.92/unit,
P < 0.01).
In multivariable analysis, BML presence and severity
predicted right and left knee replacement after adjust-
ment for age and sex. A further adjusted model examin-
ing knee replacements of the right and left knee
combined revealed that BML severity predicted knee
replacement after adjustment for a large number of con-
founders (OR 2.10, P = 0.019). A consistent trend to an
association was observed for presence of any BML at
baseline and knee replacement surgery of the right and
left combined, but this did not achieve statistical signifi-
cance in the adjusted model (OR 5.67, P = 0.124),
although the OR did not change from the univariate
analysis.
Discussion
This longitudinal study describes the natural history and
clinical significance of BMLs in a randomly selected
population of older adults. While incidence rates were
low, BMLs (assessed by measuring maximal area) were
not static, with around half either worsening or improv-
ing over the study time-frame. Change in BML size was
associated with changes in pain, but only in those with-
out established ROA. In an exploratory analysis we also
found that baseline BML severity independently pre-
dicted knee joint replacement surgery.
This is the first study to report the natural history of
BMLs in a community based sample. Many of the pre-
vious studies have been performed in symptomatic OA
cohorts, or in asymptomatic cohorts, which are not gen-
eralizable to the older population. We found that 43%
exhibited one or more BMLs at baseline. In those with
ROA the prevalence was similar. This is lower than in
studies of patients with symptomatic OA (57 to 82%
[6,14,18,19]). In the whole population, of the BMLs pre-
sent at baseline, 49% showed a change in size, with simi-
lar proportions both worsening (24%) and improving
(25%). Davies-Tuck et al. concluded that in a healthy,
pain-free population BMLs develop at a slower rate than
has been reported in OA populations, and that BMLs
are more likely to resolve [17]. Similarly we found that
BMLs increase at a slower rate in those without ROA.
However, there were no significant differences in the
rate of decreasing/resolving BMLs between the two sub-
groups. We found that 8% and 14% of BMLs completely
resolved in those with and without ROA, respectively.
This is much lower than Davies-Tuck et al.’ss t u d yi n
healthy asymptomatic subjects which reported that 46%
resolved [17]. In subjects with prevalent knee OA or at
risk for OA, Roemer et al. reported that nearly 41%
resolved [15]. The conflicting data on the natural history
of BMLs may be due to a combination of factors;
including different BML grading systems among studies,
the diversity within study samples, as well as the
Table 5 Relationship between knee replacement surgerynd baseline BMLs of the right knee*
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) † P-value
Left knee replacement (n = 7)
BML severity (0 to 8) 1.92 (1.40, 2.62) <0.01 2.78 (1.58, 4.90) <0.01†
BML presence/absence 4.60 (0.88, 24.05) 0.07 12.85 (1.82, 90.91) 0.011†
Right knee replacement (n = 8)
BML severity (0 to 8) 2.75 (1.81, 4.18) <0.01 2.88 (1.84, 4.52) <0.01†
BML presence/absence # 20.75 (3.17, a) <0.01 22.63 (3.72, a) <0.01†
Knee replacement right and left (n = 12)
BML severity (0 to 8) 2.04 (1.55, 2.69) <0.01 2.10 (1.13, 3.90) 0.019‡
BML presence/absence 5.67 (1.51, 21.32) 0.01 5.67 (0.62, 51.77) 0.124‡
*No knee replacement versus a knee replacement of the left, right, and right and left combined and baseline BMLs (measured on the ordinal scale and ranged
from 0 to 12, which was the sum of the BML scores at all four sites).
95% CI, 95% confidence interval; BMLs, bone marrow lesions; OR, odds ratio
#Using exact logistic regression because all 8 subjects who had a right knee replacement had a BML present.
†Adjusted for age and sex.
‡Further adjusted for body mass index, knee pain, leg strength, cartilage defects, tibial bone area, and radiographic osteoarthritis.
Boldface denotes statistically significant result.
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Page 8 of 12variation in study designs. We assessed BMLs by mea-
suring the maximal area at baseline and follow-up. We
then calculated whether there was an actual change in
BML size from baseline to follow-up using the LSC [36],
which takes into account measurement error and the
correlation between measurements at baseline and fol-
low-up. This formula provides a realistic and clinically
relevant tool to identify detectable difference greater
than that expected from measurement error.
In our study, the incidence of new BMLs in subjects
who were BML free at baseline was low (7%). Most stu-
dies which report BML incidence have been performed
in symptomatic OA cohorts [6,14,37]. Hunter et al.
reported that a new BML developed in 20% of knees in
a population with primary knee OA [6]. Similarly, Kor-
naat et al. reported that BML incidence was 21% in
patients with OA [14]. In subjects with prevalent knee
OA or at risk for OA, Roemer et al. reported an inci-
d e n c eo fn e a r l y3 3 %[ 1 5 ] .O u ri n c i d e n c er a t eo f7 %i s
lower than that being described in symptomatic popula-
tions; in fact, it is even lower to what was reported in
asymptomatic subjects without clinical knee OA (14%)
[17]. One reason could be because this was a commu-
nity based sample. However, as we have seen, the nat-
u r a lh i s t o r yo fB M L si ns i m i l a rp o p u l a t i o n si sq u i t e
variable. It is likely that multiple factors contribute to
the development of BMLs. A recent study has demon-
strated a possible influence of physical effects on BMLs.
In a cross-sectional design, Stehling et al. found that the
prevalence of bone marrow abnormalities increased with
the level of physical activity [38]. Our current study is
the first to report BML incidence in a community based
s a m p l ea n di tm a yb et h a tB M L sv a r yc o n s i d e r a b l yi n
nature because they are a result of many contributing
factors.
We have found the relationship between BMLs and a
change in knee pain is different for those with and with-
out ROA. A change in BML size was associated with
changes in pain as assessed by WOMAC scores, only in
those without ROA, even after adjustment for a large
number of factors that have been linked to knee pain
[39]. A one-unit change in pain score would require a
140 mm
2 increase or decrease in BML area. This novel
finding suggests that fluctuating knee pain may be attri-
butable to BMLs in those participants with early stage
disease. One explanation could be that once the disease
progresses, there is other structural pathology contribut-
ing to knee pain. Indeed, we did find that those with
R O Aw e r em o r el i k e l yt oh a v eaB M Lp r e s e n ta tm u l t i -
p l es i t e s ,s op e r h a p sac h a n g ei no n eB M Lm a yn o t
result in a symptomatic change because of other BMLs
present. To support this, a previous cross-sectional
study from this cohort using the ordinal BML scores
found that prevalence of knee pain increased with the
number of sites BMLs were present on [26]. This was
independent of knee ROA. Other studies have also sug-
gested that the size of BML is strongly related to knee
pain [3,16,40]. These studies included people with ROA;
therefore, it is unclear why, in the current study, BML
changes were not associated with pain changes in those
with ROA. This finding will need to be confirmed in
future studies.
Further analysis with the WOMAC pain sub-scales
demonstrated consistent results in those without ROA.
We found that changes in BML size was associated with
changes in knee pain when walking on a flat surface,
going up and down stairs, and at night while in bed.
Interestingly, to the best of our knowledge, this is the
first study to demonstrate that a decrease in BML size
was associated with an improvement in knee pain. This
relationship was seen in those without ROA. There are
increasing data to suggest that BMLs are reversible
[14,15,17] and using areal measure of BML size, we
h a v ef o u n dt h a tad e c r e a s ei sa s s o c i a t e dw i t hap o s i t i v e
clinical outcome. This has important implications for
intervention studies. Currently there is no disease-modi-
fying osteoarthritis drugs (DMOADs) available to mod-
ify structural progression in OA; therefore, structure
modification is now a primary aim in clinical drug trials.
We believe there is increasing evidence to suggest that
BMLs are a promising target. BMLs predict important
disease outcomes such as cartilage loss and knee repla-
cement, have the potential to regress and resolve, and
are strongly linked to knee pain. Therefore, by targeting
BMLs, it may be possible to slow disease progression as
well as reduce pain in patients with OA. BMLs are
visualised using standard fluid-sensitive sequences; how-
ever, new advanced imaging analysis techniques (such as
T1rho and T2 relaxation time quantification, and
delayed gadolinium-enhanced MRI of cartilage (dGEM-
RIC)) have been developed. dGEMRIC measures glyco-
saminoglycan (GAG) concentrations in articular
cartilage and GAG content can change quickly, there-
fore dGEMRIC can be used to determine if altering
BML natural history improves cartilage biochemistry.
There is no doubt that both standard and advanced
MRI techniques will play an important role in guiding
future treatments in OA.
Our exploratory analysis of the relationship between
BMLs and knee replacement surgery revealed that base-
line BML severity independently predicted knee replace-
ment both before and after adjustment for confounding
factors. The estimate changed little after adjustment for
pain severity and radiographic change, indicating that
the effect of BMLs on joint replacement was not
mediated through these well-established drivers of joint
replacement [20,21]. This suggests that BMLs may
themselves be a marker of fast progression and this in
Dore et al. Arthritis Research & Therapy 2010, 12:R223
http://arthritis-research.com/content/12/6/R223
Page 9 of 12turn could explain why BMLs of the right knee pre-
dicted both right and left knee replacements. However,
in view of the small numbers of knee replacement, these
results need to be interpretedw i t hc a u t i o na n dr e q u i r e
confirmation in larger studies.
We have previously published data on the demo-
graphic associations with BMLs. In a separate study we
showed that BMLs were more common with increasing
age, male sex, and increasing BMI [41]. In the current
study we did not find an association between age and
BMLs; however, male sex remained a predictor of BML
increases. It is unclear why males are more likely to
develop BMLs. It is possible this is linked to knee
trauma and knee injuries but systemic and metabolic
factors may also play a role. Identifying risk factors and
biomarkers for disease outcomes such as BMLs is
important as it might shed light on the pathogenesis of
OA. It is now understood that BMLs are an important
feature in OA; however, further work is required to
identify a more complete set of risk factors which
should include both demographic, environment, and
lifestyle factors, combined with MRI biomarkers.
This study does have potential limitations. First, for
the current study, 704 were not included due to decom-
missioning of the MRI scanner at follow-up. There were
no significant differences between those studied and the
rest of the cohort in regards to demographics, ROA,
WOMAC function or stiffness scores, AQoL scores, or
leg strength. However, those studied had a modestly
lower WOMAC pain score. Second, as previously men-
tioned, the numbers of knee replacement were limited.
While we were able to adjust for many confounding fac-
tors in the knee replacement analysis, we had insuffi-
cient data on tibial cartilage loss to adjust for this, as we
only had follow-up cartilage volume data on 3 out of
the 12 subjects who underwent knee replacement sur-
gery. We also did not have data on effusion which has
been shown to predict knee replacement [22]. Last,
BML area was measured from the slice with the greatest
BML size. This may bias towards shallow but flat
lesions; however, it is customary to measure BMLs this
way. The majority of previous studies also grade BMLs
on the slice with the greatest BML size; however, they
use a semi-quantitative scale (0 to 3) rather than an
areal measure. We acknowledge that our measure of
BMLs is only a surrogate measure of volume. Recent
methods have been developed to measure BML volume
using a autoregression model, as well as BML signal
intensity [42,43]. It is our view that the slice thickness
(4 mm) and interslice gap (0.5 to 1.0 mm) of our ima-
ging protocol was too large to estimate volume with suf-
ficient accuracy. Both the slice thickness and the
interslice gap are likely to impact on the areal BML
measurements. It is possible that a shallow BML may
not be detected if it lies within the interslice gap. Also,
some lesions may be underestimated depending on
where the slice has been taken. Smaller slice thicknesses
allow for more slices to be taken and thus help to
reduce measurement error. Although we acknowledge
these factors as limitations it is important to consider
t h ee f f e c ts i z e sw eh a v es h o w n .A1 4 0m m
2 change in
BML areal size led to a one-unit change in pain. This
change is greater than what would be expected due
to measurement error alone, as our calculated LSC was
25 mm
2.
Conclusions
In conclusion, BMLs (assessed by measuring maximal
area) were not static, with similar proportions both wor-
sening and improving in this population-based sample.
A change in BML size was associated with changes in
pain in those without ROA. This finding suggests that
fluctuating knee pain may be attributable to BMLs in
those participants with early stage disease. Baseline
BMLs also predicted knee replacement surgery. These
findings suggest therapeutic interventions aimed at alter-
ing the natural history of BMLs should be considered.
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